AMN HEALTHCARE SERVICES INC

AMN

$1.20B

Small Cap

NASDAQServices-Help Supply Services🇺🇸North AmericaDALLAS3.0K employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

AMN News

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How AMN's past catalysts played out

earningsMay 2025+8%earningsFeb 2025+7%earningsNov 2024-29%earningsAug 2024-7%earningsMay 2024-10%earningsAug 2023-12%earningsMay 2023+7%earningsNov 2022-9%

Drug Pipeline

No drugs found in this phase.

📑

Catalyst DossierPRO

The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.

→

Market-Implied Move

Regulatory Approvals

Frequently asked questions

When is AMN HEALTHCARE SERVICES INC's next FDA catalyst?→

CatalystAlert tracks every upcoming catalyst for AMN HEALTHCARE SERVICES INC (AMN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track AMN biotech catalysts?→

Add AMN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow AMN HEALTHCARE SERVICES INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply